Buchumschlag

Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Soo Borson, Rhoda Au, Anna H. Chodos, Sam Gandy, Holly Jain, Amy Alagor, Kristi Cohn, Diana R. Kerwin, Jacobo Mintzer, Stephanie Monroe, Delecia Robinson, Michelle M. Mielke, Donna M. Wilcock
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Implementing a biomarker‐enabled care pathway to accelerate identification of early‐stage Alzheimer’s disease in primary care
von: Soo Borson, et al.
Veröffentlicht: (2024)

Sex‐specific blood biomarkers linked to memory changes in middle‐aged adults: The Framingham Heart Study
von: Huitong Ding, et al.
Veröffentlicht: (2024)

Considerations for specialized maternal–fetal care in the Somali‐American community
von: Stephanie A. Eyerly‐Webb, et al.
Veröffentlicht: (2024)

Fetal phenotype and diagnosis of autosomal dominant Robinow syndrome due to novel DVL1 variant
von: Carly M. Smith, et al.
Veröffentlicht: (2024)

Knowledge gaps and confidence in counseling about aneuploidy screening and testing: A survey of prenatal care clinicians
von: M. M. Thorsen, et al.
Veröffentlicht: (2024)

Exploring cognitive progression subtypes in the Framingham Heart Study
von: Huitong Ding, et al.
Veröffentlicht: (2024)

Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
von: Thomas Claessen, et al.
Veröffentlicht: (2026)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
von: Robert Perneczky, et al.
Veröffentlicht: (2025)

The primary care brain health navigator: A perspective on implementation
von: Deanna R. Willis, et al.
Veröffentlicht: (2026)

Traditional healing and medicine in dementia care for Indigenous populations in North America, Australia, and New Zealand: Exploring culturally‐safe dementia care policy from a global perspective
von: Hom Lal Shrestha, et al.
Veröffentlicht: (2024)

Prenatal cardiac findings and 22q11.2 deletion syndrome: Fetal detection and evaluation
von: Elizabeth Goldmuntz, et al.
Veröffentlicht: (2024)

The vicious cycle of stigma: A multi‐level analysis of dementia help seeking and care in Malaysia
von: Jennifer N. W. Lim, et al.
Veröffentlicht: (2026)

Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
von: Ayesha Fawad, et al.
Veröffentlicht: (2026)

Observed/Expected Lung‐To‐Head Ratio and Total Lung Volumes That Identify Fetuses With Severe Congenital Diaphragmatic Hernia in a North American Fetal Center
von: Juliana Gebb, et al.
Veröffentlicht: (2025)

Enlarged cavum septum pellucidum and small thymus as markers for 22q11.2 deletion syndrome
von: Kimberly B. Gaiser, et al.
Veröffentlicht: (2024)

Dengue fever as a cause of hemophagocytic lymphohistiocytosis
von: Noely Hein
Veröffentlicht: (2015)

Screening tools for oropharyngeal dysphagia in stroke
von: Tatiana Magalhães de Almeida
Veröffentlicht: (2015)

Deep Learning–Based Segmentation of Fetal Anatomical Structures in the First Trimester
von: Subeen Hong, et al.
Veröffentlicht: (2026)

Association between BrainAGE and Alzheimer's disease biomarkers
von: Yousaf Abughofah, et al.
Veröffentlicht: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
von: Thomas Claessen, et al.
Veröffentlicht: (2025)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
von: Sofia Toniolo, et al.
Veröffentlicht: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
von: Russell Banks, et al.
Veröffentlicht: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
von: Andrée‐Ann Baril, et al.
Veröffentlicht: (2024)

Fas-ligand and caspase-3 positivity in three cases of histiocytic sarcoma: a different etiopathogenic pathway?
von: Cristiano Claudino Oliveira
Veröffentlicht: (2018)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
von: Julius Opwonya, et al.
Veröffentlicht: (2024)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
von: John T. O'Brien
Veröffentlicht: (2025)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
von: Katharina Bolsewig, et al.
Veröffentlicht: (2024)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
von: Darren M. Lipnicki, et al.
Veröffentlicht: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
von: Soheil Mohammadi, et al.
Veröffentlicht: (2025)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
von: Steffi De Meyer, et al.
Veröffentlicht: (2025)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
von: Emily K. Schworer, et al.
Veröffentlicht: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
von: Lars Frings, et al.
Veröffentlicht: (2025)

Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's disease
von: Alireza Shaabanpoor Haghighi, et al.
Veröffentlicht: (2025)

Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
von: Christopher Gonzalez Corona, et al.
Veröffentlicht: (2026)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
von: Frederikke Kragh Clemmensen, et al.
Veröffentlicht: (2026)

ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes
von: Luciana Mascarenhas Fonseca, et al.
Veröffentlicht: (2024)

Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
von: Oana C. Marian, et al.
Veröffentlicht: (2025)

Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
von: Patrick H. Luckett, et al.
Veröffentlicht: (2026)

Subjective memory concerns and AD/ADRD plasma biomarker associations in HABS‐HD
von: Kelsey R. Thomas, et al.
Veröffentlicht: (2026)

Changes in Alzheimer's disease blood biomarkers in kidney failure before and after kidney transplant
von: Anneka E. Blankenship, et al.
Veröffentlicht: (2024)